As of 2024-12-15, the Relative Valuation of GlaxoSmithKline PLC (GSK.L) is 2,790.63 GBP. This relative valuation is based on P/E multiples. With the latest stock price at 1,329.50 GBP, the upside of GlaxoSmithKline PLC based on Relative Valuation is 109.9%.
The range of the Relative Valuation is 1,670.60 - 3,934.79 GBP.
| Range | Selected | |
| Trailing P/E multiples | 17.0x - 23.7x | 20.9x |
| Forward P/E multiples | 23.7x - 28.5x | 25.5x |
| Fair Price | 1,670.60 - 3,934.79 | 2,790.63 |
| Upside | 25.7% - 196.0% | 109.9% |
| Date | P/E |
| 2024-12-13 | 13.50 |
| 2024-12-12 | 13.54 |
| 2024-12-11 | 13.61 |
| 2024-12-10 | 13.94 |
| 2024-12-09 | 14.04 |
| 2024-12-06 | 13.64 |
| 2024-12-05 | 13.62 |
| 2024-12-04 | 13.76 |
| 2024-12-03 | 13.89 |
| 2024-12-02 | 13.62 |
| 2024-11-29 | 13.55 |
| 2024-11-28 | 13.61 |
| 2024-11-27 | 13.64 |
| 2024-11-26 | 13.58 |
| 2024-11-25 | 13.67 |
| 2024-11-22 | 13.62 |
| 2024-11-21 | 13.29 |
| 2024-11-20 | 13.20 |
| 2024-11-19 | 13.23 |
| 2024-11-18 | 13.30 |
| 2024-11-15 | 13.21 |
| 2024-11-14 | 13.74 |
| 2024-11-13 | 13.83 |
| 2024-11-12 | 13.90 |
| 2024-11-11 | 14.18 |
| 2024-11-08 | 14.02 |
| 2024-11-07 | 14.01 |
| 2024-11-06 | 13.91 |
| 2024-11-05 | 14.13 |
| 2024-11-04 | 14.36 |
| 2024-11-01 | 14.41 |
| 2024-10-31 | 14.14 |
| 2024-10-30 | 14.28 |
| 2024-10-29 | 14.74 |
| 2024-10-28 | 14.74 |
| 2024-10-25 | 14.71 |
| 2024-10-24 | 14.78 |
| 2024-10-23 | 14.70 |
| 2024-10-22 | 14.76 |
| 2024-10-21 | 14.86 |
| 2024-10-18 | 14.98 |
| 2024-10-17 | 15.19 |
| 2024-10-16 | 15.19 |
| 2024-10-15 | 15.17 |
| 2024-10-14 | 15.17 |
| 2024-10-11 | 15.03 |
| 2024-10-10 | 15.28 |
| 2024-10-09 | 14.80 |
| 2024-10-08 | 14.75 |
| 2024-10-07 | 15.03 |